Refer a friend to Doherty Clinical Trials via our DCT Engagement Community database and once they have completed a study with us, you will receive a referral bonus.
Receive up to $500 every time a friend completes their first study at Doherty Clinical Trials.
Doherty Clinical Trials Limited is proud to announce the commencement of the CHIVAS-M1 study (Controlled Human Infection for Vaccination Against Streptococcus pyogenes M1UK), which will help drive medical research and development of a vaccine against Streptococcus pyogenes, otherwise known as Strep A.
Senior Lab Manager, Vanessa Mollard represented Doherty Clinical Trials at the forum in Canberra
Dr Andrew Brockway's panel, 'Clinical Trials in Australia: Performance, Competitive Advantages, Challenges and Evolving Policy' at AusBiotech 2024
Highlighting the vital work of Doherty Clinical Trials and sharing why participants find it so rewarding.
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}